NewGenIvf's shares and warrants are expected to begin trading
on the Nasdaq Capital Market under the tickers "NIVF" and "NIVFW",
respectively, on April 4,
2024
NEW
YORK, April 3, 2024 /PRNewswire/ -- NewGenIvf
Limited ("NewGen" or the "Company"), a comprehensive fertility
services provider in Asia helping
couples and individuals obtain access to fertility treatments, and
A SPAC I Acquisition Corp. (NASDAQ: ASCA) ("A SPAC I"), a publicly
traded special purpose acquisition company, today announced the
completion of their previously announced business combination (the
"Business Combination"). The combined company will be named
"NewGenIvf Group Limited" ("NewGenIvf Group") and its shares and
warrants are expected to begin trading on the Nasdaq Capital Market
under the tickers "NIVF", and "NIVFW", respectively, on
April 4, 2024.
Mr. Siu Wing Fung Alfred,
Founder, Chairman, and CEO of NewGen commented, "We are thrilled to
announce our upcoming debut on the Nasdaq as we complete our
business combination with A SPAC I. Demand for fertility services
is growing across Asia, and we are
uniquely positioned to take advantage of this emerging opportunity.
We believe our public listing will help us to accelerate our growth
and execute on our long-term vision, bolstering our ability to
provide accessible, comprehensive fertility solutions to
individuals and couples who need them. I am proud of all we have
accomplished to date, and I am eager to begin the next phase of our
company's journey."
Claudius Tsang, CEO, CFO and
Chairman of A SPAC I, commented, "We are excited to complete the
Business Combination, and to see what NewGen will accomplish in
this new chapter of its story. We believe that the company will
continue to play a significant role in Asia's burgeoning fertility services
market."
Advisors
Jun He Law Offices served as the legal advisor to NewGen in
connection with the Transaction.
Loeb & Loeb LLP and Ogier served as legal counsel to A SPAC
I in connection with the Transaction.
About NewGen
NewGen is a comprehensive fertility services provider in
Asia helping couples and
individuals obtain access to fertility treatments. With a mission
to aid couples and individuals in building families regardless of
fertility challenges, NewGen has dedicated itself to creating
increased access to infertility treatment and providing
comprehensive fertility services for its customers. NewGen Group
and its management have over a decade of experience in the
fertility industry. NewGen's clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of
services for its patients, including comprehensive infertility and
assisted reproductive technology treatments, egg and sperm
donation, and surrogacy, in the appropriate jurisdictions,
respectively. To learn more, visit www.newgenivf.com. The
information contained on, or accessible through, NewGen's website
is not incorporated by reference into this press release, and you
should not consider it a part of this press release.
About A SPAC I Acquisition Corp.
A SPAC I Acquisition Corp. was a blank check company sponsored
by A SPAC (Holdings) Acquisition Corp., a British Virgin Islands company, and formed for
the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business
combination with one or more businesses or entities.
Forward-Looking Statements
This press release contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally are identified by the words
"believe," "project," "expect," "anticipate," "estimate," "intend,"
"strategy," "future," "opportunity," "plan," "may," "should,"
"will," "would," "will be," "will continue," "will likely result,"
and similar expressions. Without limiting the generality of the
foregoing, the forward-looking statements in this press release
include descriptions of the Company's or NewGenIvf Group's future
commercial operations. Forward-looking statements are predictions,
projections and other statements about future events that are based
on current expectations and assumptions and, as a result, are
subject to risks and uncertainties. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this press release, such as the Company's or
NewGenIvf Group's inability to implement its business plans,
identify and realize additional opportunities, or meet or exceed
its financial projections and changes in the regulatory or
competitive environment in which the Company or NewGenIvf Group
operates. You should carefully consider the foregoing factors and
the other risks and uncertainties described in NewGenIvf Group's
Annual Report on Form 20-F and other documents filed or to be filed
by NewGenIvf Group's with the U.S. Securities and Exchange
Commission (the "SEC") from time to time, which could cause actual
events and results to differ materially from those contained in the
forward-looking statements. Copies of these documents are available
on the SEC's website, www.sec.gov. All information provided herein
is as of the date of this press release, and the Company and
NewGenIvf Group undertakes no obligation to update any
forward-looking statement, except as required under applicable
law.
View original
content:https://www.prnewswire.com/news-releases/newgenivf-and-a-spac-i-announce-closing-of-business-combination-302106831.html
SOURCE A SPAC I Acquisition Corp.
